Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01825707 · ClinicalTrials.gov registry record · Phase 1
AME Study of [14C]-YH4808 in Healthy Male Subjects
A Phase 1 study, sponsored by Yuhan Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT01825707: Completed Phase 1 study, sponsored by Yuhan Corporation.
NCT01825707 is a Phase 1 study that has completed, run by Yuhan Corporation. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01825707, a Phase 1 study, has completed, sponsored by Yuhan Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the absorption, metabolism, and excretion (AME) kinetics of YH4808 and to determine and characterize metabolites present in plasma, urine, and feces in man following a single dose of \[14C\] YH4808 200 mg (\~100 µCi ±20 µCi) administered as a single oral dose.
Primary Outcome
* Maximum observed concentration in plasma, whole blood, urine, and feces * Time to maximum observed concentration in plasma, whole blood, urine, and feces * Area under the concentration-time curve from Hour 0 to the last measurable concentration * Assessment of Mass balance
Interventions
- DRUG [14C]-YH4808 200 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-03 |
| Phase | Phase 1 |
What the finished NCT01825707 record still lists
NCT01825707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which [14C]-YH4808 200 mg is the first listed.
NCT01825707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01825707 about?
NCT01825707 is a clinical study titled "AME Study of [14C]-YH4808 in Healthy Male Subjects". The purpose of this study is to determine the absorption, metabolism, and excretion (AME) kinetics of YH4808 and to determine and characterize metabolites present in plasma, urine, and feces in man following a single dose of \[14C\] YH4808 200 mg (\~100 µCi ±20 µCi) administered as a single oral dos...
What is the current status of trial NCT01825707?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2013-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01825707?
The interventions under investigation include: [14C]-YH4808 200 mg (DRUG).
Who is sponsoring clinical trial NCT01825707?
This trial is sponsored by Yuhan Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01825707's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia